ANLN and pachyonychia congenita: Although ANLN can drive the progression of PC through multiple pathways, further research is required to clarify its role in immune escape mechanisms, facilitate the development of targeted therapies, and support the clinical validation of exosomal ANLN in combination with biomarkers.